Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 53,084,883	$ 47,278,685	$ 160,995,005	$ 131,192,729
Cost of revenues		9,845,793	13,780,309	38,816,865	37,256,066
Gross profit		43,239,090	33,498,376	122,178,140	93,936,663
Operating expenses:
Selling, general and administrative expenses		16,597,032	13,446,618	43,784,637	46,885,138
Stock-based compensation		12,807,455		12,807,455
Misappropriation loss			28,516		380,766
Total operating expenses		29,404,487	13,475,134	56,592,092	47,265,904
Income from operations		13,834,603	20,023,242	65,586,048	46,670,759
Other income (expenses):
Interest income		7,950	10,234	37,283	86,345
Interest expense		(5,466)	(3,978)	(15,898)	(37,380)
Other income		65,922	1,138,869	721,894	3,875,723
Other expenses		(795,158)	(98,314)	(2,746,450)	(581,239)
Gain on disposal of subsidiary				3,813,609
Total other income (expenses)		(726,752)	1,046,811	1,810,438	3,343,449
Income before income taxes		13,107,851	21,070,053	67,396,486	50,014,208
Income tax expense		10,273,384	13,012,262	27,254,478	25,683,244
Net income		2,834,467	8,057,791	40,142,008	24,330,964
Less: net income (loss) attributable to non-controlling interests		1,573	(298,623)	66,954	(696,812)
Net income attributable to SBC Medical Group Holdings Incorporated		2,832,894	8,356,414	40,075,054	25,027,776
Other comprehensive income (loss):
Foreign currency translation adjustment		20,783,646	(974,249)	1,543,245	(19,825,222)
Reclassification of unrealized gain on available-for-sale debt security to net income when realized, net of tax effect of nil and $(97,856) for the three months ended September 30, 2024 and 2023, respectively; nil and $(97,856) for the nine months ended September 30, 2024 and 2023, respectively			(205,383)		(8,760)
Total comprehensive income		23,618,113	6,878,159	41,685,253	4,496,982
Less: comprehensive income (loss) attributable to non-controlling interests		180,093	(387,948)	110,093	(1,129,475)
Comprehensive income attributable to SBC Medical Group Holdings Incorporated		$ 23,438,020	$ 7,266,107	$ 41,575,160	$ 5,626,457
Net income per share attributable to SBC Medical Group Holdings Incorporated - Basic	[1]	$ 0.03	$ 0.09	$ 0.42	$ 0.27
Net income per share attributable to SBC Medical Group Holdings Incorporated - Diluted	[1]	$ 0.03	$ 0.09	$ 0.42	$ 0.27
Weighted average shares outstanding - Basic	[1]	95,095,144	94,192,433	94,495,533	94,192,433
Weighted average shares outstanding - Diluted	[1]	95,095,144	94,192,433	94,495,533	94,192,433
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 51,209,243	$ 45,119,709	$ 152,718,488	$ 125,336,653
Nonrelated Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 1,875,640	$ 2,158,976	$ 8,276,517	$ 5,856,076

[1] Retrospectively restated for effect of reverse recapitalization on September 17, 2024.